搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
News Medical on MSN
3 天
Impact of oxidative stress, gut, and diet on attention deficit hyperactivity disorder ...
Oxidative stress and gut microbiome interactions are key in ADHD pathogenesis, with diet playing a crucial role in managing ...
10 天
新开发策略!将肿瘤药物研发成功率从5%提高到35%
然而,令人失望的是,仅有20-42%的这些新获批抗肿瘤药物,能够达到由ASCO和ESMO设定的临床获益标准,即延长总生存期超过2.5个月。另外40%新批的抗肿瘤药物延长生存期2周至2.5个月,有30%新批的抗肿瘤药物未能改善总生存期。
Frontiers
4 天
Unveiling the Multifaceted Processes in Acute Brain Injury Pathophysiology
The present Frontiers Research Topic aims to unite studies under the scope of dynamic events following acute brain injuries. This comprehensive topic will embrace the vascular, electrical and ...
9 天
趴着午睡,是怎么毁掉你的身体的
趴着午睡,是怎么毁掉你的身体的,肌肉,驼背,午睡,颈部疼痛 ...
8 天
趴着午睡,会给身体带来多大伤害?
只用一张桌子来午睡的艰苦条件下,我们很可能会枕着自己的胳膊或手背来给头部支撑,或者避免脸和硬硬的桌面直接接触。这种看似舒服的做法,实际上会导致手、腕、臂和肘部的神经受压或血流不足,时间久了,就会产生麻木和刺痛感 [2]。 神经受压(nerve ...
1 天
on MSN
Study warns high serum magnesium levels in septic patients linked to increased mortality
Sepsis is one of the most common life-threatening conditions in intensive care units, with approximately 48.9 million cases ...
ophthalmologytimes
7 小时
Stealth BioTherapeutics presents preclinical data on bevemipretide's retinal delivery in ...
The data were presented at the Keystone Symposium Targeting Dry Age-related Macular Degeneration: Pathophysiology and ...
来自MSN
25 天
Exploring OTUB1's influence on protein stability and atherosclerosis pathophysiology
The study investigates the role of the deubiquitinase OTUB1 in vascular smooth muscle cells (VSMCs) within the context of ...
2 天
on MSN
Gaining insights into the chemical basis of aversive learning
One of the things that makes brains so incredibly difficult to understand is their ability to adjust and adapt. Our learning ...
Medscape
1 天
Will 'Game-Changer' Antipsychotic Live Up to the Hype?
The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈